agilon health shareholders approve 2026 meeting items
agilon health, inc. reported the results of its annual stockholder meeting held on June 2, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
agilon health, inc. reported the results of its annual stockholder meeting held on June 2, 2026. Stockholders elected three Class II directors—Diana McKenzie, Karen McLoughlin, and Ronald Williams—to serve until the 2029 annual meeting.
Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
independent registered public accounting firm regulatory
non-binding vote on executive compensation financial
annual meeting of stockholders regulatory
Class II directors regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did agilon health (AGL) stockholders vote on at the 2026 annual meeting?
Which directors were elected to agilon health (AGL)’s board in 2026?
Did agilon health (AGL) stockholders ratify the company’s independent auditor for 2026?
How did agilon health (AGL) stockholders vote on executive compensation in 2026?
What are broker non-votes in agilon health (AGL)’s 2026 meeting results?
AI-generated analysis. How Rhea-AI works. Not financial advice.